With the help of single-cell sequencing, metabolic assessment, and gene-edited human models, Landberg et al. studied isocitrate dehydrogenase 1 (IDH1) mutant preleukemic hematopoietic stem cells, proposing target for treatment. Click here to learn more:htt
RT @BCD_AACR: Attending today's #AACR24 Major Symposium on IDH-mutant cancers? Check out recent work from Ravi Majeti (@majetilab) on speci…
Attending today's #AACR24 Major Symposium on IDH-mutant cancers? Check out recent work from Ravi Majeti (@majetilab) on specific targeting of IDH1-mutant stem cells: https://t.co/q9O5djL784 #leusm @AACR https://t.co/wW0rttC3j0
RT @BCD_AACR: #AACR24 session on Understanding and Treating #AML will feature speaker Ravi Majeti (@majetilab) on pre-#leukemia mutations a…